Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia
Saved in:
| Published in: | Haematologica - the Hematology journal |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301674339532801 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Haematologica - the Hematology journal |
| description | |
| discipline_display | Hematology |
| discipline_facet | Hematology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:69076 |
| institution | FRELIP |
| journal_source_facet | Haematologica - the Hematology journal |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia Hematology General Hematology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Hematology General Hematology Hematology General Hematology |
| subject_facet | Hematology General Hematology |
| title | Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia |
| title_auth | Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia |
| title_full | Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia |
| title_fullStr | Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia |
| title_full_unstemmed | Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia |
| title_short | Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia |
| title_sort | tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory b-cell acute lymphoblastic leukemia |
| topic | Hematology General Hematology |
| url | https://haematologica.org/article/view/13081 |